DIAGENS Funding: $101M Raised, IPO (2026)

DIAGENS is based in Hangzhou, China. It has raised $101M in total funding. Latest round: IPO.

DIAGENS funding overview

DIAGENS is based in Hangzhou, China. DIAGENS has raised $101M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO announced in March 2026. The round record for DIAGENS runs through 2026; nothing later has been disclosed.

DIAGENS at a glance

Total raised
$101M
Latest round
IPO
Latest round date
March 2026
Headquarters
Hangzhou, China

Frequently asked about DIAGENS funding

How much has DIAGENS raised?
DIAGENS has raised $101M in total disclosed funding across the rounds on record.
Who has invested in DIAGENS?
No investors are named on the public record for DIAGENS yet.
What was the latest DIAGENS funding round?
The most recent disclosed round is an IPO, announced in March 2026.
Where is DIAGENS based?
DIAGENS is based in Hangzhou, China.
When did DIAGENS last raise?
The last disclosed DIAGENS round closed in March 2026 at IPO.

Round data for DIAGENS is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Hangzhou and backer lists below.

Companies related to DIAGENS (18)

Browse related funding lists (3)

Company funding database · Investor directory · Founder database · Mega-rounds 2026